What is the new opioid free pain killer? A Look at Suzetrigine (Journavx)
•
4 min read
In the U.S., more than 80 million people receive prescriptions for acute pain annually, with opioids often being the standard treatment [1.3.7]. The critical question, **what is the new opioid free pain killer?**, now has a promising answer: suzetrigine (brand name Journavx), a first-in-class medication approved by the FDA in January 2025 [1.2.5, 1.4.2].
